Search for: "ELI LILLY & CO." Results 801 - 820 of 1,004
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Apr 2009, 8:05 am
Dass ein Nebeneinander beider Verfahren nicht nur zu doppelter Belastung und widersprechenden Entscheidungen, sondern auch zu prozessualer Verwirrung  (und in der Folge Verärgerung des nationalen Richters)  führen kann, bezeugt eine kürzlich ergangene Entscheidung  des Court of Appeal for England and Wales in der Sache  Eli Lilly & Co… [read post]
9 Apr 2009, 7:52 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent Infringement Updates) (Patently-O) (Patent Docs) Xigris (Drotrecogin alfa) –US: CAFC: Pioneering claims require more expansive written description: Ariad v… [read post]
6 Apr 2009, 8:20 am
" Among those companies ordered "to stop using the ads" were "Merck & Co., Roche Holding AG, Bayer AG, Johnson & Johnson, Forest Laboratories Inc., Eli Lilly & Co., Boehringer Ingelheim GmbH, Genentech Inc., GlaxoSmithKline Plc and Novartis AG. [read post]
3 Apr 2009, 1:05 am
The appellate court upheld the Texas federal district court ruling that granted summary judgment to Eli Lilly on the grounds that the plaintiff's doctor informed him of the risks of taking Zyprexa. [read post]
20 Mar 2009, 2:05 am
Eli Lilly & Co., 774 F.2d 830, 835 (7th Cir. 1985); Martinkovic v. [read post]
16 Mar 2009, 11:20 am
  The report points out that this new analysis was funded by Amylin Pharmaceuticals Inc., the drug company that makes Byetta, and Eli Lilly & Co., which is Amylin's marketing partner for Byetta sales in the U.S. [read post]
13 Mar 2009, 2:00 am
(GenericsWeb) India’s Human Genome Bill (Spicy IP) Indian drugmakers push into US generics market (GenericsWeb) Uganda: Indian generic manufacturers concerned anti-counterfeit legislation may threaten market in Uganda and surrounding territories (Afro-IP) UK: Court of Appeal admonishes counsel for dilatory actions involved in parallel British and EPO proceedings: Eli Lilly & Co v Human Genome Sciences (Hal Wegner) (PatLit) US: President Obama to lift stem… [read post]
6 Mar 2009, 7:41 pm
Supreme Court ruled that federal approval of a drug is no protection from lawsuits in state courts over safety issues that arise later -- a decision that could have implications for Eli Lilly and Co. and other pharmaceutical makers. [read post]
5 Mar 2009, 10:22 am
Byetta is a diabetes drug co-marketed in the U.S. by Amylin Pharmaceuticals Inc., based in San Diego, and Eli Lilly & Co., of Indianapolis. [read post]
27 Feb 2009, 9:48 am
Kaul appears to be the phone calls from the Eli Lilly & Co. representatives. [read post]